Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
GRFS
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
finance.yahoo.comPOSITIVO
Are Options Traders Betting on a Big Move in Grifols Stock?
Investors in Grifols, S.A. GRFS need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 20, 2026 $2 Call had some of the highest implied volatility of all equity options today. What is…
Grifols (BME:GRF) Stock May Be Below Fair Value On Earnings
Grifols has seen a long share price slide in recent years, which naturally puts the focus on one question for investors who still follow the stock. Is the current price tag properly supported by the earnings the business is generating toda…
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading; Down for Week
European equities traded in the US as American depositary receipts were tracking modestly higher lat PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
GRFS vs. SDZNY: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical - Drugs stocks have likely encountered both Grifols (GRFS) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two stocks presents investors with the better value opportunity right now? Let's…
European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading
European equities traded in the US as American depositary receipts were trending lower late Thursday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
GRFS or SDZNY: Which Is the Better Value Stock Right Now?
Investors interested in Medical - Drugs stocks are likely familiar with Grifols (GRFS) and Sandoz Group AG Sponsored ADR (SDZNY). But which of these two companies is the best option for those looking for undervalued stocks? Let's take a cl…
European Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading
European equities traded in the US as American depositary receipts were trending slightly higher lat PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
European equities traded in the US as American depositary receipts were tracking higher late Wednesd PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
OPSEU/SEFPO: Permanently end for-profit plasma collection to protect public health
Toronto, Aug. 14, 2026 (GLOBE NEWSWIRE) -- The union that represents Canadian Blood Services (CBS) workers in Ontario is calling for an immediate termination of the blood-plasma collection contract with for-profit Spanish pharmaceutical co…
Can Asceniv Help ADMA Stock Combat IG Market Challenges?
ADMA Biologics ADMA is a U.S.-based commercial-stage biopharmaceutical company focused on developing, manufacturing and marketing specialty biologics for immunodeficient patients and individuals at risk of certain infectious diseases. The…
European Equities Traded in the US as American Depositary Receipts Edge Up in Wednesday Trading
European equities traded in the US as American depositary receipts were edging higher late Wednesday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
FOXO TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS FROM GRIFOLS BIO SUPPLIES, INC.
FOXO Technologies Inc. WEST PALM BEACH, FL, July 29, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc.'s (OTC: FOXOD/FOXO) ( "FOXO") subsidiary, Vector BioSource, Inc. ("Vector") today announced that it has entered into a definitive agreemen…
Image source: The Motley Fool. DATE Tuesday, July 28, 2026 at 12:30 p.m. ET CALL PARTICIPANTS Head of Investor Relations and sustainability - Daniel SegarraChief Executive Officer - Nacho AbiaPresident of BioPharma - Roland WandelerChief F…
Grifols SA (GRFS) (H1 2026) Earnings Call Highlights: Strong Biopharma Growth and Strategic ...
This article first appeared on GuruFocus. Revenue: EUR3,574 million for the first half, up 2.6% at constant currency. Biopharma Revenue Growth: 5.4% growth at constant currency. Adjusted EBITDA: EUR472 million in Q2, EUR854 million for the…
Grifols (BME:GRF) Starts Phase 3 Trials As Undervalued Narrative Faces A Fresh Test
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Grifols (BME:GRF) has started dosing patients in two Phase 3 trials for its immunoglobulin therap…
Here are the major earnings before the open Tuesday
Major earnings expected before the bell on Tuesday include: * PayPal Holdings (PYPL [https://seekingalpha.com/symbol/PYPL]) * The Coca-Cola Company (KO [https://seekingalpha.com/symbol/KO]) * The Boeing Company (BA [https://seekingalpha.co…
European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading
European equities traded in the US as American depositary receipts started the week slightly higher PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium ne…
European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading
European equities traded in the US as American depositary receipts were tracking lower late Thursday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading
European equities traded in the US as American depositary receipts started the week lower late Monda PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Grifols Doses First Patients in Two Phase 3 Trials to Expand Indications of its Flagship Immunoglobulins
Grifols, S.A. One trial, SIGMA, will evaluate Grifols' intravenous immunoglobulin (Ig) GAMUNEX®-C (immune globulin injection [human], 10% caprylate chromatography purified) plus standard medical treatment in patients with secondary immunod…
European Equities Traded in the US as American Depositary Receipts Advance Wednesday
European equities traded in the US as American depositary receipts were rising on Wednesday morning, PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Is ADMA Stock's 13.5% Monthly Gain a Sign of Recovery?
ADMA Biologics, Inc.'s ADMA shares have gained 13.5% in a month compared with the industry's growth of 8.2%. The recovery will relieve anxious investors as the stock had taken a massive beating since March-end. ADMA Biologics markets plasm…
Jazz Pharmaceuticals and AbCellera Biologics Inc. (ABCL) Announce Collaboration
AbCellera Biologics Inc. (NASDAQ:ABCL) is among the Best Pharmaceutical Stocks.On June 17, 2026, AbCellera Biologics Inc. (NASDAQ:ABCL) and Jazz Pharmaceuticals entered a preclinical research collaboration, option, and license agreement. T…
Grifols (GRFS) Launches FESILTY in the U.S. for Congenital Fibrinogen Deficiency Treatment
Grifols (NASDAQ:GRFS) is one of the top value stocks to buy under $10. On June 15, Grifols launched FESILTY in the US for treating acute bleeding in pediatric and adult patients with congenital fibrinogen deficiency/CFD, excluding dysfibri…
Grifols Launches FESILTY™ (fibrinogen, human-chmt) in the U.S.
Grifols, S.A. The new fibrinogen concentrate, approved in the U.S. for acute bleeding episodes in pediatric and adult patients with congenital fibrinogen deficiency, is now available in the U.S. FESILTY complements Grifols' bleeding manage…
European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading
European equities traded in the US as American depositary receipts were trending higher late Tuesday PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
European equities traded in the US as American depositary receipts kicked off the week higher late M PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Grifols, S.A. (GRFS) Sees Strong Biopharma Growth Led by Gamunex and Yimmugo
We recently compiled a list of the 11 Most Undervalued Pharma Stocks to Invest In. Grifols, S.A. (NASDAQ:GRFS) is among the most undervalued stocks. TheFly reported on May 12 that Deutsche Bank reduced its price target on GRFS from €11 to…
Kennametal Stock Is Up 50%. Here's What a $181 Million Fund Sale Could Mean
Key Points Brandes Investment Partners sold 4,965,772 shares of Kennametal last quarter; the estimated transaction value was $180.99 million based on quarterly average pricing. Meanwhile, the quarter-end position value decreased by $100.43…
Kennametal Stock Is Up 50%. Here's What a $181 Million Fund Sale Could Mean
Brandes Investment Partners reduced its stake in Kennametal(NYSE:KMT) by 4,965,772 shares in the first quarter, an estimated $180.99 million trade based on quarterly average pricing, according to a May 15, 2026, SEC filing. What happened A…
Can Asceniv Help ADMA Navigate the Current IG Market Challenges?
ADMA Biologics ADMA develops and commercializes plasma-derived biologics used to treat immune deficiencies and help prevent certain infectious diseases. The company currently generates revenues from three FDA-approved products: Bivigam, an…
How The Grifols (BME:GRF) Investment Story Is Shifting With New Analyst Caution
Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Analysts have trimmed their fair value price target for Grifols fro…
Will the IG Market Challenges Affect ADMA Biologics Prospects in 2026?
ADMA Biologics ADMA markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases. The company’s top line currently comprises sales of three FDA-approved products — Bivigam (an…
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
European equities traded in the US as American depositary receipts were trending slightly higher lat PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
European Equities Traded in US as ADRs Rise in Wednesday Trading
European equities traded in the US as American depositary receipts rose Wednesday with the S&P Europ PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
Is it Time to Exit ADMA Biologics Stock After a 22% Monthly Plunge?
ADMA Biologics’ ADMA shares have crashed 21.8% over the past month compared with the industry’s decline of 6.8%. The stock has also underperformed the sector and the S&P 500 Index in this time frame. ADMA Underperforms Industry, Sector & S…